Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Brain Cancer|Gastrointestinal Cancers|Genitourinary Cancers|Gynecologic Cancers|Head and Neck Cancers|Melanoma|Thoracic Cancers
Interventions: DRUG: IGF-Methotrexate conjugate
Sponsor: IGF Oncology, LLC